Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jonathan E. Freeman currently holds 32,655 shares of Phio Pharmaceuticals Corp. (PHIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan E. Freeman has been a net neutral trader of PHIO stock. They have purchased $0 and sold $0 worth of shares.
Jonathan E. Freeman's most recent insider trade was on Feb 5, 2026, when they sold 16,600 shares at $0.00 per share.
Jonathan E. Freeman serves as Executive at Phio Pharmaceuticals Corp. (PHIO). They have executed 8 insider transactions totaling $0 over their tenure at the company.
Jonathan E. Freeman holds the position of Executive at Phio Pharmaceuticals Corp., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Jonathan E. Freeman has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Jonathan E. Freeman was on Feb 5, 2026, when they purchased $0 worth of PHIO shares. This transaction involved 16,600 shares at N/A per share.
Jonathan E. Freeman currently owns 32,655 shares of Phio Pharmaceuticals Corp. (PHIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jonathan E. Freeman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jonathan E. Freeman has 8 Form 4 filings on record as an insider at Phio Pharmaceuticals Corp..
Set alerts for Jonathan E. Freeman and 40,000+ other insiders.